MLICM
SRGA

Metropolitan Life Insurance Company (MetLife)’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-718
Closed -$91.6K – 2649
2019
Q2 		$91.6K Hold
718
– – ﹤0.01% 2350
2019
Q1 		$129K Sell
718
-12
-2% -$1.74K ﹤0.01% 2173
2018
Q4 		$81K Buy
+730
New +$95.1K ﹤0.01% 2401
2018
Q3 		– Sell
-671
Closed -$92.6K – 2637
2018
Q2 		$92.6K Buy
671
+111
+20% +$15.3K ﹤0.01% 2362
2018
Q1 		$77.3K Buy
560
+226
+68% +$30.8K ﹤0.01% 2397
2017
Q4 		$41K Sell
334
-998
-75% -$137K ﹤0.01% 2480
2017
Q3 		$182K Sell
1,332
-234
-15% -$35.3K ﹤0.01% 2322
2017
Q2 		$275K Hold
1,566
– – ﹤0.01% 2139
2017
Q1 		$188K Buy
+1,566
New +$163K ﹤0.01% 2305
2016
Q3 		– Sell
-1,425
Closed -$153K – 2658
2016
Q2 		$153K Hold
1,425
– – ﹤0.01% 2509
2016
Q1 		$171K Buy
1,425
+27
+2% +$2.84K ﹤0.01% 2264
2015
Q4 		$167K Hold
1,398
– – ﹤0.01% 2374
2015
Q3 		$238K Buy
1,398
+573
+69% +$110K ﹤0.01% 2161
2015
Q2 		$160K Sell
825
-788
-49% -$146K ﹤0.01% 2516
2015
Q1 		$239K Sell
1,613
-5
-0.3% -$761 ﹤0.01% 1974
2014
Q4 		$252K Hold
1,618
– – ﹤0.01% 2242
2014
Q3 		$232K Buy
1,618
+757
+88% +$110K ﹤0.01% 2269
2014
Q2 		$112K Sell
861
-721
-46% -$91.6K ﹤0.01% 2677
2014
Q1 		$194K Buy
+1,582
New +$171K ﹤0.01% 2478
2013
Q4 		– Sell
-1,687
Closed -$189K – 2766
2013
Q3 		$189K Hold
1,687
– – ﹤0.01% 2467
2013
Q2 		$190K Buy
+1,687
New +$206K ﹤0.01% 2385

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SRGA Position: Q3 2019 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2019, closing a stake of 718 shares — an estimated $91.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SRGA in Q2 2013 and held it in 21 quarters. The position peaked at $275K in Q2 2017. 97 funds tracked by Wall St. Rank hold SRGA as of Q3 2019.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 718 Surgalign Holdings, Inc. Common Stock shares in Q3 2019, an estimated $91.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 21 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Surgalign Holdings, Inc. Common Stock position peaked at $275K in Q2 2017.
  • 97 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2019.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2019, filed 14 Nov 2019.